Want to see FATE full AI Analyst Report?
Fate Therapeutics (FATE) Ownership Overview
12.42% Insiders
12.29% Mutual Funds
17.64% Other Institutional Investors
5.57% ETFs
52.08% Public Companies and
Individual Investors
The ownership structure of Fate Therapeutics (FATE) stock is a mix of institutional, retail, and individual investors. Approximately 35.50% of the company’s stock is owned by Institutional Investors, 12.42% is owned by Insiders, and 52.08% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 05, 2026 | xxxxxxxxxxxxx | $107670 | |
Aug 05, 2026 | xxxxxxxxxxxxx | $95060 | |
May 21, 2026 | xxxxxxxxxxxxx | $54418 | |
May 21, 2026 | xxxxxxxxxxxxx | $47853 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $2670808 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $38202 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $431055 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,884,277 | Insider | 10.75% | 31,179,950 | |
| 4,730,098 | Institution | 3.95% | 11,446,837 | |
| 4,078,078 | Institution | 3.40% | 9,868,949 | |
| 2,904,835 | Institution | 2.42% | 7,029,701 | |
| 1,227,770 | Institution | 1.02% | 2,971,203 | |
| 1,026,171 | Institution | 0.86% | 2,483,334 | |
| 989,188 | Institution | 0.83% | 2,393,835 | |
| 958,570 | Institution | 0.80% | 2,319,739 | |
| 789,188 | Institution | 0.66% | 1,909,835 | |
| 644,596 | Institution | 0.54% | 1,559,922 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,078,078 | Institution | 3.40% | 9,868,949 | |
| 2,904,835 | Institution | 2.42% | 7,029,701 | |
| 1,227,770 | Institution | 1.02% | 2,971,203 | |
| 1,026,171 | Institution | 0.86% | 2,483,334 | |
| 958,570 | Institution | 0.80% | 2,319,739 | |
| 789,188 | Institution | 0.66% | 1,909,835 | |
| 623,027 | Institution | 0.52% | 1,507,725 | |
| 512,952 | Institution | 0.43% | 1,241,344 | |
| 367,000 | Institution | 0.31% | 888,140 | |
| 308,409 | Institution | 0.26% | 746,350 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,194,411 | Institution | 2.67% | 7,826,307 | |
| 1,191,711 | Institution | 0.99% | 2,919,692 | |
| 502,166 | Institution | 0.42% | 1,230,307 | |
| 387,392 | Institution | 0.32% | 937,489 | |
| 283,032 | Institution | 0.24% | 693,428 | |
| 228,000 | Institution | 0.19% | 551,760 | |
| 183,774 | Institution | 0.15% | 450,246 | |
| 127,948 | Institution | 0.11% | 313,473 | |
| 104,580 | Institution | 0.09% | 256,221 | |
| 69,821 | Institution | 0.06% | 198,292 |
FAQ
Who Owns Fate Therapeutics (FATE)?
According to the latest TipRanks data, approximately 17.64% of the company's stock is held by institutional investors, 12.42% is held by insiders, and 52.08% is held by retail investors.
What percentage of Fate Therapeutics (FATE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.64% of Fate Therapeutics (FATE) stock is held by institutional investors.
What percentage of Fate Therapeutics (FATE) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.08% of Fate Therapeutics (FATE) stock is held by retail investors.
Who owns the most shares of Fate Therapeutics (FATE)?
Redmile Group, Llc owns the most shares of Fate Therapeutics (FATE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.